Elimination of frequent vital sign monitoring in patients receiving paclitaxel
Thomas, M.
Oncology Nursing Forum 25(5): 828
1998
ISSN/ISBN: 0190-535X PMID: 9644696 Document Number: 496574
Document emailed within 1 workday
Related Documents
Wojciechowska-Lacka, A.; Markowska, J.; Skasko, E.; Kruczek, A.; Steffen, J. 2003: Frequent disease progression and early recurrence in patients with familial ovarian cancer primarily treated with paclitaxel and cis- or carboplatin (preliminary report) European Journal of Gynaecological Oncology 24(1): 21-24Paul, L.J.; Cohen, P.R. 2012: Paclitaxel-associated subungual pyogenic granuloma: report in a patient with breast cancer receiving paclitaxel and review of drug-induced pyogenic granulomas adjacent to and beneath the nail Journal of Drugs in Dermatology: Jdd 11(2): 262-268
Setel, P.W.; Sankoh, O.; Rao, C.; Velkoff, V.A.; Mathers, C.; Gonghuan, Y.; Hemed, Y.; Jha, P.; Lopez, A.D. 2005: Sample registration of vital events with verbal autopsy: a renewed commitment to measuring and monitoring vital statistics Bulletin of the World Health Organization 83(8): 611-617
Setel, P.W.; Sankoh, O.; Rao, C.; Velkoff, V.A.; Mathers, C.; Gonghuan, Y.; Hemed, Y.; Jha, P.; Lopez, A.D. 2005: Sample registration of vital events with verbal autopsy: a renewed commitment to measuring and monitoring vital statistics Bulletin of the World Health Organization 83(8): 611-617
Setel, P.W.; Sankoh, O.; Rao, C.; Velkoff, V.A.; Mathers, C.; Gonghuan, Y.; Hemed, Y.; Jha, P.; Lopez, A.D. 2005: Sample registration of vital events with verbal autopsy: a renewed commitment to measuring and monitoring vital statistics Bulletin of the World Health Organization 83(8): 611-617
Kalra, S.; Verma, K.; Singh Balhara, Y.P. 2017: The sixth vital sign in diabetes JPMA. Journal of the Pakistan Medical Association 67(11): 1775-1776
Horiguchi, J.; Oyama, T.; Takata, D.; Rokutanda, N.; Nagaoka, R.; Odawara, H.; Tokiniwa, H.; Tozuka, K.; Kikuchi, M.; Sato, A.; Takeyoshi, I. 2011: Pathological complete response and prognosis in patients receiving neoadjuvant paclitaxel and trastuzumab with and without anthracyclines for stage II and III, HER2-positive operable breast cancer: a single-institute experience Anticancer Research 31(9): 3041-3046
Rogez, E.; Thiais, S. 1995: Care and monitoring of patients receiving home chemotherapy Revue de l'Infirmiere 3: 37-40
Cortez-Gann, J.; Dicarlo Gilmore, K.; Watson Foley, K.; Brooke Kennedy, M.; Mcgee, T.; Kring, D. 2017: Blood Transfusion Vital Sign Frequency: what Does the Evidence Say? Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses 26(2): 89-92
Godard, P. 2005: The control of asthma: a vital sign to be assessed on each consultation Presse Medicale 34(4): 267-268
Katzman, G.H. 1995: The newborn's SpO2: a routine vital sign whose time has come? Pediatrics 95(1): 161-162
Winkler, M.; Ringe, B.; Baumann, J.; Loss, M.; Wonigeit, K.; Pichlmayr, R. 1994: Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression Clinical Chemistry 40(12): 2247-2253
Chang, C.Y.; Abujaber, S.; Pany, M.J.; Obermeyer, Z. 2019: Are vital sign abnormalities associated with poor outcomes after emergency department discharge? Acute Medicine 18(2): 88-95
Capecchi, L.; Guazzini, A.; Lorini, C.; Santomauro, F.; Bonaccorsi, G. 2015: The first italian validation of the most widespread health literacy assessment tool: the Newest Vital Sign Epidemiologia e Prevenzione 39(4 Suppl 1: 124-128
Strachan, M.W.; Malloch, K.; Frier, B.M. 1997: Self monitoring of glucose by people with diabetes. Self monitoring is vital for people with impaired awareness of hypoglycaemia Bmj 315(7101): 185
2006: ACOG Committee Opinion No. 349, November 2006: Menstruation in girls and adolescents: using the menstrual cycle as a vital sign Obstetrics and Gynecology 108(5): 1323-1328
Conway, R.; Byrne, D.; O'Riordan, D.; Silke, B. 2020: Limited Prognostic Utility of a Simplified Vital Sign Based Risk Calculator in Acute Medical Admissions Acute Medicine 19(3): 138-144
Schwarz, E.B.; Parisi, S.M.; Williams, S.L.; Shevchik, G.J.; Hess, R. 2012: Promoting safe prescribing in primary care with a contraceptive vital sign: a cluster-randomized controlled trial Annals of Family Medicine 10(6): 516-522
Tabchi, S.; Kourie, H.R.; Farhat, F.; Kattan, J. 2016: Early Increase of Ca 19-9 in Advanced Pancreatic Cancer Receiving Folfirinox. Is it a Sign of Efficacy? Le Journal Medical Libanais. Lebanese Medical Journal 64(2): 97-99
Boner, G.; Kristal, H. 1983: Neoplastic disease in patients receiving dialytic therapy and in patients after receiving transplantation Harefuah 104(2): 68-69